Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal L Mackall

Showing results (141-150 of 232) with videos related to

Pageof 24
Sort By:
Neuro-Oncology|February 11, 2022
Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignanciesHaneen Shalabi, Staci Martin, Bonnie Yates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Blood Advances|October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 daysLekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Nature Medicine|October 18, 2005
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cellsHua Zhang, Kevin S Chua, Martin Guimond, et al.
Transplantation and Cellular Therapy|July 18, 2021
A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation TrialTessa M Andermann, Farnaz Fouladi, Fiona B Tamburini, et al.
Molecular Cancer|June 26, 2023
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturingHyatt Balke-Want, Vimal Keerthi, Nikolaos Gkitsas, et al.
Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.
Blood|November 25, 2025
Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to CyclosporineHitomi Hosoya, Armando N Bastidas Torres, Sebastian Fernandez-Pol, et al.
The New England Journal of Medicine|June 12, 2024
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell TherapyMark P Hamilton, Takeshi Sugio, Troy Noordenbos, et al.
Journal of the National Cancer Institute|January 31, 2019
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune EvasionSabine Heitzeneder, Elena Sotillo, Jack F Shern, et al.
Pageof 24

Showing results (141-150 of 232) with videos related to

Sort By:
Pageof 24
Neuro-Oncology|February 11, 2022
Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignanciesHaneen Shalabi, Staci Martin, Bonnie Yates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Blood Advances|October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 daysLekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Nature Medicine|October 18, 2005
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cellsHua Zhang, Kevin S Chua, Martin Guimond, et al.
Transplantation and Cellular Therapy|July 18, 2021
A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation TrialTessa M Andermann, Farnaz Fouladi, Fiona B Tamburini, et al.
Molecular Cancer|June 26, 2023
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturingHyatt Balke-Want, Vimal Keerthi, Nikolaos Gkitsas, et al.
Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.
Blood|November 25, 2025
Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to CyclosporineHitomi Hosoya, Armando N Bastidas Torres, Sebastian Fernandez-Pol, et al.
The New England Journal of Medicine|June 12, 2024
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell TherapyMark P Hamilton, Takeshi Sugio, Troy Noordenbos, et al.
Journal of the National Cancer Institute|January 31, 2019
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune EvasionSabine Heitzeneder, Elena Sotillo, Jack F Shern, et al.
Pageof 24